Market Tracker

02/28 9:33am ET

ImmunoCellular Therapeutics Ltd (NYSE MKT LLC:IMUC)

2.70
Delayed Data
As of Feb 27
 0.00 / 0.00%
Today’s Change
1.83
Today|||52-Week Range
14.80
+31.71%
Year-to-Date
No recent news for ImmunoCellular Therapeutics Ltd.

Today’s Trading

Previous close2.70
Today’s openn.a.
Day’s range-- - --
Volume0
Average volume (3 months)113,956
Market cap$9.3M
Dividend yield--
Data as of 02/27/2017

Growth & Valuation

Earnings growth (last year)+6.25%
Earnings growth (this year)-20.00%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book0.28

Competitors

 Today’s
change
Today’s
% change
YTENYield10 Bioscience I...0.000.00%
BASIBioanalytical System...+0.02+1.35%
FSIFlexible Solutions I...0.000.00%
OPGNOpGen Inc0.000.00%
Data as of 9:30am ET, 02/28/2017

Financials

Next reporting dateMarch 7, 2017
EPS forecast (this quarter)-$1.20
Annual revenue (last year)$0.00
Annual profit (last year)-$12.8M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Secretary
Gary S. Titus
President, Chief Executive Officer &
Director
Anthony J. Gringeri
Corporate headquarters
Calabasas, California

Forecasts